Drug Therapy for the Elderly

With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As a...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Wehling, Martin (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Vienna : Springer Vienna : Imprint: Springer, 2013.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03471nam a22004695i 4500
001 978-3-7091-0912-0
003 DE-He213
005 20151204183109.0
007 cr nn 008mamaa
008 120817s2013 au | s |||| 0|eng d
020 |a 9783709109120  |9 978-3-7091-0912-0 
024 7 |a 10.1007/978-3-7091-0912-0  |2 doi 
040 |d GrThAP 
050 4 |a RC952-954.6 
072 7 |a MJX  |2 bicssc 
072 7 |a MED032000  |2 bisacsh 
082 0 4 |a 618.97  |2 23 
082 0 4 |a 612.67  |2 23 
245 1 0 |a Drug Therapy for the Elderly  |h [electronic resource] /  |c edited by Martin Wehling. 
264 1 |a Vienna :  |b Springer Vienna :  |b Imprint: Springer,  |c 2013. 
300 |a XV, 356 p. 53 illus., 35 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Foreword -- Part 1: General aspects -- Part 2: Special considerations with regard to organ systems based on geriatric clinical importance -- Part 3: Pharmacotherapy and geriatric syndromes -- Part 4: Further problem areas in gerontopharmacotherapy and pragmatic recommendations. 
520 |a With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently. Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, Drug Therapy for the Elderly underlines both indispensable and dispensable elements of drug treatment, providing the practitioner with: - Background information on the elderly population regarding their needs for particular drugs (with an eye to frailty, co-morbidity patterns, and special sensitivities regarding drug metabolism and excretion) - Practical advice about drug treatment surveillance parameters in the elderly - In-depth discussion of drugs in relation to the elderly with specific diagnoses - Integration of multimorbidity/polypharmacy situations into prioritization schemes - A plan for how to deal with the complexity of polypharmacy situations in a five-minute consultation An original classification of drugs is proposed by the editor which relates the power of effects, prognostic data, and tolerability to a prioritization scoring system. This approach is the first to not only provide a negative listing, but also integrates positive data into an overall assessment for drugs fit for the aged. Therefore, Drug Therapy for the Elderly serves as a timely reference for a wide array of physicians. 
650 0 |a Medicine. 
650 0 |a Pharmacology. 
650 0 |a Internal medicine. 
650 0 |a Geriatrics. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Geriatrics/Gerontology. 
650 2 4 |a Internal Medicine. 
650 2 4 |a Pharmacology/Toxicology. 
700 1 |a Wehling, Martin.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783709109113 
856 4 0 |u http://dx.doi.org/10.1007/978-3-7091-0912-0  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)